The specialty chemicals company LANXESS AG adjusted its earnings forecast for the business year 2009 after having a significantly better-than-expected fourth quarter, according to preliminary unaudited results.
LANXESS AG is building a new chemical plant at its site in Bitterfeld, Germany. This marks the specialty chemicals group’s move into a new segment of the water treatment business.
The world’s leading synthetic rubber company LANXESS has brought forward its plans to build a new butyl rubber facility in Singapore. The company will hold a groundbreaking ceremony in May, 2010, and production is expected to start in the first quarter of 2013. The 100,000 tons per annum plant on Jurong Island will require an investment of up to EUR 400 million (575 million USD).
lit.COLOGNE to celebrate 10th anniversary from March 10 to 20, 2010 with high-profile program / Bestselling author Frank Schätzing to read from his new book “Limit” in the LANXESS arena on March 17
With its unit in Krefeld, LANXESS becomes a representative of the “Germany – Land of Ideas” initiative / The LANXESS site in Uerdingen will be a “Selected 2010 Landmark” on April 16, 2010 / Technology advance in N2O reduction through globally unique system of facilities
Q3 sales EUR 1.37 billion, up 11 % vs. Q2 / Q3 EBITDA pre exceptionals EUR 143 million, up 28 % vs. Q2 / Q3 net income positive at EUR 23 million / Chinese economy driving recovery / “Challenge09-12” generating savings earlier than planned / Outlook: FY EBITDA pre exceptionals EUR 400 to 420 million
Specialty chemicals group LANXESS AG welcomes the compromise reached between the European Commission, Council of the European Union and the European Parliament on Thursday (October 1, 2009) to introduce rules, which will mean car tires must have in the future a label clearly stating their fuel efficiency.
Today, German specialty chemicals group LANXESS and the Russian Academy of Science (RAS) – one of the world’s most distinguished scientific institutions and founded over 285 years ago – signed a cooperative research agreement.